Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma

• Main Authors: Edouard Chasseuil (Author), Mélanie Saint-Jean (Author), Hannah Chasseuil (Author), Lucie Peuvrel (Author), Gaëlle Quéreux (Author), Jean-Michel Nguyen (Author), Aurélie Gaultier (Author), Emilie Varey (Author), Amir Khammari (Author), Brigitte Dréno (Author)
• Format: Book
• Published: Medical Journals Sweden, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Nivolumab response rate is 40% in metastatic melanoma. Few studies have evaluated pre-treatment biomarkers predictive of response. The aim of this study was to identify potential peripheral blood biomarkers associated with survival in patients with advanced melanoma treated with nivolumab. All advan...